Curis, Inc.

CRISNASDAQHealthcare● Active

$0.47

$-0.00(-0.68%)

Market Cap$6191289

P/E Ratio—

52W High$3.13

52W Low$0.46

Avg Volume426K

Open$0.47

Beta3.04

Insider Trades Ownership Employees

Curis, Inc. (CRIS) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · CRIS · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

∞

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Curis, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

CRIS insider buying and selling by quarter

CRIS insider selling · CRIS insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

2.3M1.1M0

2022 Q3

2022 Q4

2023 Q1

2023 Q2

2024 Q2

2025 Q1

2025 Q2

2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · CRIS ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

CRIS executive sell shares · CRIS board member insider trading · CRIS insider trading SEC filing

Showing 12 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Mar 31, 2026	KAITIN KENNETH I Director	Purchase	10,000	$0.55	$5K	11,407	Form 4
Mar 20, 2026	Zung Jonathan B. CDO	Other	66,667	—	—	66,667	Form 4
Mar 20, 2026	Hamdy Ahmed MD CMO	Other	66,667	—	—	66,667	Form 4
Mar 20, 2026	Duvall Diantha CFO	Other	66,666	—	—	77,707	Form 4
Mar 20, 2026	Dentzer James E President & CEO · Director	Other	133,333	—	—	148,730	Form 4
Mar 20, 2026	Rubin Marc Director	Other	26,667	—	—	28,108	Form 4
Jan 27, 2022	Dentzer James E President & CEO · Director	Sale	2,406	$3.18	$8K	67,971	Form 4
Jan 31, 2022	Dentzer James E President & CEO · Director	Sale	3,094	$3.07	$9K	64,877	Form 4
Jan 25, 2021	Dentzer James E President & CEO · Director	Sale	2,283	$10.96	$25K	70,362	Form 4
Jan 26, 2021	Dentzer James E President & CEO · Director	Sale	3,094	$10.59	$33K	67,268	Form 4
Jan 23, 2020	Dentzer James E President & CEO · Director	Sale	3,658	$1.69	$6K	45,252	Form 4
Jan 24, 2020	Dentzer James E President & CEO · Director	Sale	3,094	$1.64	$5K	42,158	Form 4

KAITIN KENNETH I

Director

Purchase

Date

Mar 31

10,000

Price

$0.55

Value

$5K

View Form 4 on SEC.gov

Zung Jonathan B.

CDO

Other

Date

Mar 20

66,667

Price

—

Value

—

View Form 4 on SEC.gov

Hamdy Ahmed MD

CMO

Other

Date

Mar 20

66,667

Price

—

Value

—

View Form 4 on SEC.gov

Duvall Diantha

CFO

Other

Date

Mar 20

66,666

Price

—

Value

—

View Form 4 on SEC.gov

Dentzer James E

President & CEO · Director

Other

Date

Mar 20

133,333

Price

—

Value

—

View Form 4 on SEC.gov

Rubin Marc

Director

Other

Date

Mar 20

26,667

Price

—

Value

—

View Form 4 on SEC.gov

Dentzer James E

President & CEO · Director

Sale

Date

Jan 27

2,406

Price

$3.18

Value

$8K

View Form 4 on SEC.gov

Dentzer James E

President & CEO · Director

Sale

Date

Jan 31

3,094

Price

$3.07

Value

$9K

View Form 4 on SEC.gov

Dentzer James E

President & CEO · Director

Sale

Date

Jan 25

2,283

Price

$10.96

Value

$25K

View Form 4 on SEC.gov

Dentzer James E

President & CEO · Director

Sale

Date

Jan 26

3,094

Price

$10.59

Value

$33K

View Form 4 on SEC.gov

Dentzer James E

President & CEO · Director

Sale

Date

Jan 23

3,658

Price

$1.69

Value

$6K

View Form 4 on SEC.gov

Dentzer James E

President & CEO · Director

Sale

Date

Jan 24

3,094

Price

$1.64

Value

$5K

View Form 4 on SEC.gov

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About CRIS insider trading

CRIS insider trades

Curis, Inc. (CRIS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including KAITIN KENNETH I (Director), Zung Jonathan B. (CDO), Hamdy Ahmed MD (CMO). Over the past 12 months, 5 insiders have filed transactions with the SEC. CRIS insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Curis, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

CRIS insider trading · 5 questions

The insiders of Curis, Inc. (CRIS) include executives and directors such as KAITIN KENNETH I (Director), Zung Jonathan B. (CDO), Hamdy Ahmed MD (CMO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

CRIS board member insider tradingwho are CRIS insidersCRIS insider rosterCuris, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026